Effect of inhaled corticosteroids on bone mineral density in childhood asthma: Comparison of fluticasone propionate with beclomethasone dipropionate

Osteoporosis International

Volumn 8, Issue 5, 1998, Pages 418-422

  Gregson, R K ^a,b   Rao, R ^a   Murrills, A J ^b   Taylor, P A ^b   Warner, J O ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Asthma; Bone mineral density; Childhood; Corticosteroids; Growth

Indexed keywords

BECLOMETASONE DIPROPIONATE; CORTICOSTEROID; FLUTICASONE PROPIONATE;

ARTICLE; ASTHMA; BODY FAT; BONE DENSITY; BONE MINERAL; CHILD; CLINICAL ARTICLE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUMBAR SPINE; MALE; PRIORITY JOURNAL; TIME;

ADIPOSE TISSUE; ADMINISTRATION, TOPICAL; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BECLOMETHASONE; BONE DENSITY; CHILD; CHILD, PRESCHOOL; DENSITOMETRY, X-RAY; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; LUMBAR VERTEBRAE; MALE;

EID: 0031791698     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001980050085     Document Type: Article

References (25)

1. Warner JO, Neijens HJ, Landau L. et al. Asthma: a follow-up statement from an international paediatric asthma consensus group. Arch Dis Child 1992;67:240-8.
2. The British guidelines on asthma management: 1995 review and position statement. Thorax 1997;52:S1-29.
3. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994;88:373-81.
4. Nikolaizak WH, Marchant JL, Preece MA, et al. Endocrine and luns function in asthmatic children on inhaled corticosteroids. Am J Resp Crit Care Med 1994;150:624-8.
5. Doull IJM, Freezer NJ, Holgate ST. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med 1995;151:1715-9.
6. Thomas BC, Stanhope R, Grant DB. Impaired growth in children with asthma during treatment with conventional doses of inhaled corticosteroids. Acta Paediatr 1994;83:196-9.
7. Wolthers OD, Pedersen S. Short term growth during treatment with inhaled fluticasone propionate and beclomethasone dipropionate. Arch Dis Child 1993;68:673-6.
8. Barnes N, Hallet C, Harris TAJ. Meta analysis of the efficacy and safety of fluticasone propionate (FP) compared to budesonide (BUD). Eur Resp J 1996;9(Suppl 23):404-7.
9. Gustafsson P, Tsanakas J, Gold M, Primhak R, Radford M, Gillies E. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 μg/day with inhaled beclomethasone dipropionate 400 μg/day in mild and moderate asthma. Arch Dis Child 1993;69:206-11.
10. Bone growth in children. Lunar News 1993:[October]:2-4.
11. Matkovic V, Kostial K, Simonovic I, Buzina R, et al. Bone status and fracture rates in two regions of Yugoslavia. Am J Clin Nutr 1979;32-540-9.
12. Glastre C, Braillou P, David L, et al. Measurement of bone mineral content of the lumbar spine by dual energy X-ray absorptiometry in normal children: correlations with growth parameters. J Clin Endocrinol Metab 1990;70:1330-3.
13. Bonjour J, Theintz G, Buchs B, et al. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Endocrinol Metab 1991;73:555-63.
14. Locascio V, Bonucci E, Imbibo B, et al. Bone loss in response to long-term glucocorticoid therapy. Bone Miner 1990;8:39-51.
15. Reid DM, Nicoll JJ, Smith MA, et al. Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. BMJ 1986,293:1363-6.
16. Reid IR, Chapman GE, Frayer TRC, et al. Low serum osteocalcin levels in glucocorticoid-treated asthmatics. J Clin Endocrinol Metab 1986;62:379-83
17. Jennings BH, Andersson KE, Johansson SA. Assessment of systemic effects of inhaled glucocorticoids, comparison of effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover. Eur J Clin Pharmacol 1991;40:77-82.
18. Birkebaek NH, Esberg G, Andersen K, et al. Bone and collagen turnover during treatment with inhaled dry powder budesonide and beclomethasone dipropionate. Arch Dis Child 1995,73:524-7.
19. Kinberg KA, Hopp RJ, Biven RE, Gallagher JC. Bone mineral density in normal and asthmatic children. J Allergy Clin Immunol 1994;94:490-7.
20. Sorva R, Turpinen M, Juntunen-Backman K, et al. Effects of inhaled budesonide on serum markers of bone metabolism in children with asthma. J Allergy Clin Immunol 1992;90:808-15.
21. Konig P, Hillman L, Cervantes C, Levine C, Maloney C, Douglass B, et al. Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate. J Pediatr 1993;122:219-26.
22. Baraldi E, Bollini MC, De Marchi A, Zacchello. Effect of beclomethasone dipropionate on bone mineral content assessed by x-ray densitometry in asthmatic children: a longitudinal evaluation. Eur Respir J 1994;7:710-4.
23. Hopp RJ, Degan JA, Biven RE, et al. Longitudinal assessment of bone mineral density in children with chronic asthma. Ann Allergy 1995;75:143-8.
24. Hopp RJ, Degan JA, Phelan J, Lappe J, Gallagher GC. Cross-sectional study of bone density in asthmatic children. Pediatr Pulmonol 1995;20:189-92.
25. Martinati LC, Bertoldo F, Gaspen E, Micelli S, Boner AL. Effect on cortical and trabecular bone mass of different anti-inflammatory treatments in preadolescent children with chronic asthma. Am J Respir Crit Care Med 1996;153:232-6.